Ocean Biomedical, Inc.

OCEA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$9,480-$114,466-$958-$62,344
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$745$1,205$0$56,550
Change in WC$1,043$1,181$1,735$4,741
Other Non-Cash$3,512$102,651-$1,524$0
Operating Cash Flow-$4,180-$9,429-$747-$1,053
Investing Activities
PP&E Inv.$0$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$2,100-$107,100
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$2,100-$107,100
Financing Activities
Debt Repay.$3,400$6,808$2,100$0
Stock Issued$0$15,768$0$1,017
Stock Repurch.$0-$64,282$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$52,105$0$96
Financing Cash Flow$3,400$10,399$2,100$1,113
Forex Effect$0$0$0$107,100
Net Chg. in Cash-$780$970-$747$60
Supplemental Information
Beg. Cash$1,004$34$1,076$0
End Cash$224$1,004$328$60
Free Cash Flow-$4,180-$9,429-$747-$1,053